Skip to main content
Clinical Trials/CTRI/2020/12/030147
CTRI/2020/12/030147
Recruiting
Phase 4

Comparative study of efficacy, safety and patient compliance of Dapagliflozin and Metformin Vs Vildagliptin and Metformin combination therapy in newly diagnosed Type 2 diabetes patients

Kumar Gautam0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Kumar Gautam
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Kumar Gautam

Eligibility Criteria

Inclusion Criteria

  • 1\)Newly diagnosed T2DM patients with or without metformin therapy 2\)HbA1C \>\=7\.5 3\)Age 18\-75 yrs

Exclusion Criteria

  • 1\)Type 1DM, Patient taking metformin 1000mg/day with poor glycemic control
  • 2\)eGFR \<45 ml/min/1\.73m2
  • 4\)Pregnancy
  • 5\)Lactation
  • 6\)Patients with Child bearing potential
  • 7\)Active Malignancy 8\)Chronic inflammatory disorders
  • 9\)Chronic alcoholism
  • 10\)History of pancreatitis

Outcomes

Primary Outcomes

Not specified

Similar Trials